Clinical Trial Detail

NCT ID NCT03311672
Title T-Cell PET Imaging With [18F]F-AraG in Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

lung non-small cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.